These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34866841)

  • 1. Treatment for Hepatocellular Carcinoma in South Asia.
    Acharya SK
    J Clin Exp Hepatol; 2021; 11(6):641-645. PubMed ID: 34866841
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma.
    Hur MH; Lee JH; Kim JY; Hong JH; Park MK; Cho HJ; Choi NR; Kim J; Kim MA; Nam JY; Lee YB; Cho EJ; Yu SJ; Kim YJ; Lee DH; Lee JM; Hong SK; Yi NJ; Lee KW; Suh KS; Yoon JH
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of re-resection versus radiofrequency ablation for recurrent Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma (HCC) after resection for primary HCC.
    Yin X; Hua T; Liang C; Chen Z
    Transl Cancer Res; 2019 Aug; 8(4):1035-1045. PubMed ID: 35116847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.
    Zhuang BW; Li W; Wang W; Li B; Lu MD; Kuang M; Xie XH; Xie XY
    Eur Radiol; 2021 Jul; 31(7):5379-5389. PubMed ID: 33404697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan.
    Wu CC; Tseng CW; Tseng KC; Chen YC; Wu TW; Chang SY; Chang YJ; Chao YC; Hsu CS
    J Formos Med Assoc; 2021 May; 120(5):1249-1258. PubMed ID: 33288401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
    Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
    J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observation of surgical resection combined radiofrequency in patients with CNLC Ⅱa~Ⅲa stage multiple hepatocellular carcinoma].
    Zhang JD; Zhang X; Pei ZJ; Yue P; Bai B; Lin YY; Meng WB; Li X
    Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(28):2195-2202. PubMed ID: 34333931
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis.
    Gui CH; Baey S; D'cruz RT; Shelat VG
    Eur J Surg Oncol; 2020 May; 46(5):763-771. PubMed ID: 31937433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis.
    Guglielmi A; Ruzzenente A; Valdegamberi A; Pachera S; Campagnaro T; D'Onofrio M; Martone E; Nicoli P; Iacono C
    J Gastrointest Surg; 2008 Jan; 12(1):192-8. PubMed ID: 17999123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases.
    Huang J; Hernandez-Alejandro R; Croome KP; Yan L; Wu H; Chen Z; Prasoon P; Zeng Y
    J Gastrointest Surg; 2011 Feb; 15(2):311-20. PubMed ID: 21052859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency Ablation versus Resection in Large Single Nodule of Hepatocellular Carcinoma: an Evidence-based Case Report.
    Widjaja FF; Kalista KF; Kurniawan J
    Acta Med Indones; 2018 Oct; 50(4):346-352. PubMed ID: 30631002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
    BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes.
    Nobuoka D; Motomura Y; Shirakawa H; Yoshikawa T; Kuronuma T; Takahashi M; Nakachi K; Ishii H; Furuse J; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kinoshita T; Komori H; Baba H; Fujiwara T; Nakatsura T
    Int J Oncol; 2012 Jan; 40(1):63-70. PubMed ID: 21922136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
    Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma.
    Zhou C; Peng Y; Zhou K; Zhang L; Zhang X; Yu L; Hu J; Chen F; Qiu S; Zhou J; Fan J; Ren Z; Wang Z
    Hepatobiliary Surg Nutr; 2019 Feb; 8(1):19-28. PubMed ID: 30881962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
    Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
    J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.